Events

Reuters Pharma USA 2025 will unite senior pharma leaders across commercial, marketing, medical affairs, patient engagement, market access, real world evidence and data for two...

In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements to enable presymptomatic diagnosis...

Join us in March for an exciting three-day exploration into the future of medicines manufacturing research and innovation! CMAC, a medicines manufacturing research centre located...

Global biopharmaceutical leaders continue to make significant strides in retinal disease treatments; as Bayer and Regeneron make headway with its high-dose version of Eylea (Eylea...

Over the past year, the Treg sector has seen groundbreaking investments and strategic collaborations between leading biotech and pharma companies like Quell and AstraZeneca, and...

Welcome to the 8th Gene Therapy Development Summit Transforming the Future of Gene Therapies for Rare and Common Diseases With 14 new gene therapy approvals in the last 18 months...

The field of conjugatable drugs is advancing at a rapid pace, with major collaborations like Nurix and Pfizer for antibody-degrader conjugates and Bicycle and Novartis for radiopharmace...

2024 was pivotal for TCR therapies. Following the commercial approval for Adaptimmune's Tecelra, positive clinical readouts, and FIH trials from Immatics, Triumvira, Affini-T,...

With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics. Whether for nose-to-brain delivery...

Food and drug oversight, Pivotal events that shaped laws in US and scope of FDA actions, GMP vs. cGMP, Consequences of noncompliance, Avoiding over-reliance on metrics, Recent...

With Arbor Biotechnologies on-track for year-end IND/CTA filing of their LNP-mediated gene editing therapy and LNPs continuing to be the hottest delivery vehicle across all payload...

The 4th ADC Analytical Development Summit is returning to Boston in April 2025. This event will bring together the brightest minds in the field to address the unique analytical...

Enhance Purification, Process Analytics and Scalability of Your mRNA Medicines Through Improved Process Development and Manufacturing to Safeguard Efficacy and Approval Rate of...

Following the FDA's introduction of the Modernization Act 3.0 and the latest guidance on new approach methods (NAMs), GSK developing a new lung organoid model to empower pulmonary...

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations...